FMO Stockholders Litigation Settlement
Last verified September 18, 2026Source: jndHow ClaimWatch verifies cases
This settlement is closed to new claims. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →
What happened
Defendants, including Guggenheim Funds Investment Advisors and its officers and directors, allegedly caused the Fiduciary/Claymore Energy Infrastructure Fund (FMO) to over-leverage its assets and breached their fiduciary duties. Defendants allegedly pursued a March 2022 merger with Kayne Anderson Energy Infrastructure Fund to avoid personal liability from tax-related claims, rather than acting in stockholders' best interests. The defendants have agreed to pay $18.8 million to settle allegations of gross negligence and breach of fiduciary duty.
Do you qualify?
All holders of FMO common shares as of the merger closing date on March 7, 2022, whose shares were converted into KYN common stock. Excluded are the defendants, FMO trustees/officers/directors, their families, related entities, and insurance carriers.
What you can claim
Read from the official settlement notice. Confirm the terms that apply to you on the administrator's site before filing.
Direct distribution from settlement proceeds
Eligible class members receive a direct distribution from the net settlement funds based on the Plan of Allocation. No claim form is required.
Who is in the class
All holders of FMO common shares of beneficial interest as of the closing of the Merger, whose shares were converted into shares of KYN common stock, including their legal representatives, heirs, successors-in-interest, transferees, and assignees of all such foregoing holders.
Quoted from the settlement notice.
How to file
Eligible class members do not need to submit a claim form. If you held FMO shares at the March 7, 2022 merger closing and were not excluded, you will receive a direct distribution. Distributions occurred on March 6, 2025, and December 11, 2025, with subsequent rolling distributions as funds remain available. For information, contact the Settlement Administrator at 1-855-208-4128 or info@FMOStockholdersLitigation.com.
Common questions
- How much does the FMO Stockholders Litigation Settlement pay?
- The total settlement fund is $18.8M. Actual amounts depend on how many valid claims are filed — most settlements divide a fixed fund pro rata, so a higher claim rate means a smaller individual check. An "up to" figure is a cap, not a guarantee.
- Do I need proof of purchase for the FMO Stockholders Litigation Settlement?
- No. You can file without a receipt or proof of purchase. You attest that you qualify and submit basic details, though claims are still subject to review and submitting a false claim is a crime.
- Is the FMO Stockholders Litigation Settlement notice real, or a scam?
- JND Legal Administration is the settlement administrator for this case. Claims are filed at fmostockholderslitigation.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
- When will payments from the FMO Stockholders Litigation Settlement be sent?
- Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for July 9, 2024; no payments can be issued before a settlement receives final approval.
New to class actions?
This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.
More securities settlements
View all →Eagle Pharma Securities Litigation Settlement
Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.
…moreHut 8 Corp. Securities Class Action Settlement
Hut 8 Corp. and individual defendants are accused of alleged securities violations. The company and defendants have agreed to settle claims from investors who purchased securities during the class period without admitting wrongdoing.
Kornit Digital Ltd. Securities Litigation Settlement
Kornit Digital Ltd. and its executives are accused of securities fraud in this class action lawsuit. The defendants have denied all claims and admit no wrongdoing, but have agreed to settle the case for $19.5 million to eliminate the burden and expense of continued litigation.
…more